6.08
1.46%
-0.09
Handel nachbörslich:
6.09
0.010
+0.16%
Schlusskurs vom Vortag:
$6.17
Offen:
$6.15
24-Stunden-Volumen:
103.27K
Relative Volume:
0.62
Marktkapitalisierung:
$369.00M
Einnahmen:
$454.53M
Nettoeinkommen (Verlust:
$21.96M
KGV:
23.30
EPS:
0.2609
Netto-Cashflow:
$6.14M
1W Leistung:
-6.17%
1M Leistung:
-19.47%
6M Leistung:
-47.18%
1J Leistung:
-48.21%
Bioceres Crop Solutions Corp Stock (BIOX) Company Profile
Firmenname
Bioceres Crop Solutions Corp
Sektor
Branche
Telefon
54 34 1486 1100
Adresse
Ocampo 210 bis, Predio CCT, Rosario
Vergleichen Sie BIOX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
BIOX | 6.08 | 369.00M | 454.53M | 21.96M | 6.14M | 0.2609 |
MMM | 130.17 | 70.89B | 34.63B | 4.39B | 739.00M | -13.35 |
VMI | 340.25 | 6.82B | 4.05B | 299.19M | 415.80M | 7.20 |
MDU | 18.60 | 3.79B | 4.40B | 407.00M | 30.05M | 1.77 |
GFF | 74.04 | 3.72B | 2.61B | 189.37M | 335.53M | -7.39 |
SEB | 2,673.85 | 2.58B | 8.90B | -2.00M | -187.00M | 331.68 |
Bioceres Crop Solutions Corp Stock (BIOX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-04-06 | Eingeleitet | Oppenheimer | Outperform |
2022-09-30 | Eingeleitet | Canaccord Genuity | Buy |
2021-10-08 | Eingeleitet | ROTH Capital | Buy |
2021-03-15 | Eingeleitet | Lake Street | Buy |
Bioceres Crop Solutions Corp Aktie (BIOX) Neueste Nachrichten
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Shares Purchased by Fourth Sail Capital LP - MarketBeat
Equities Analysts Issue Forecasts for BIOX Q2 Earnings - Defense World
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Sees Significant Increase in Short Interest - MarketBeat
Brookline Capital Management Estimates BIOX Q2 Earnings - MarketBeat
Bioceres Crop Solutions (BIOX) Stock Drops 5.26% Amid Market Vol - GuruFocus.com
BIOX Q4 EPS Forecast Lowered by Brookline Capital Management - MarketBeat
Bioceres shares hold Outperform rating, $13 target with Oppenheimer By Investing.com - Investing.com Australia
Bioceres shares hold Outperform rating, $13 target with Oppenheimer - Investing.com
A Closer Look at 7 Analyst Recommendations For Bioceres Crop Solutions - Benzinga
Canaccord Genuity Group Cuts Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $9.50 - MarketBeat
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Q1 2025 Earnings Call Transcript - Insider Monkey
Bioceres Crop Solutions Corp (BIOX) Q1 2025 Earnings Call Highlights: Navigating Revenue ... - Yahoo Finance
Bioceres Crop Solutions Reports Q1 2025 Financial Results - TipRanks
Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting (NASDAQ:BIOX) - Seeking Alpha
Earnings call: Bioceres reports decline amid Argentina drought, remains optimistic - Investing.com
BIOX stock touches 52-week low at $6.27 amid market challenges - Investing.com India
Bioceres Crop: Fiscal Q1 Earnings Snapshot - The Washington Post
BIOXBioceres Crop Solutions Corp. Ordinary Shares Latest Stock News & Market Updates - StockTitan
Bioceres Crop Solutions Reports Fiscal First Quarter 2025 Financial and Operational Results - StockTitan
Bioceres Crop Solutions Corp (BIOX) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Examining the Future: Bioceres Crop Solutions's Earnings Outlook - Benzinga
Bioceres Crop Solutions (BIOX) Scheduled to Post Earnings on Monday - MarketBeat
Bioceres Crop Solutions to Host Fiscal First Quarter 2025 Financial Results Conference Call on Tuesday, November 12, 2024 at 8:30 a.m. Eastern Time - Lelezard
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $12.25 Consensus PT from Analysts - MarketBeat
How the (BIOX) price action is used to our Advantage - Stock Traders Daily
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) top owners are private companies with 42% stake, while 34% is held by individual investors - Yahoo Finance
BIOX stock touches 52-week low at $7.15 amid market challenges - Investing.com
Fourth Sail Capital LP Bolsters Stake in Bioceres Crop Solutions Corp - GuruFocus.com
Oppenheimer lowers Bioceres shares’ price target, citing challenging planting conditions in Argentina and Brazil - Investing.com
Oppenheimer Lowers Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $13.00 - MarketBeat
Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Lowered to $10.00 at Canaccord Genuity Group - Defense World
(BIOX) Investment Analysis - Stock Traders Daily
5 Analysts Assess Bioceres Crop Solutions: What You Need To Know - Benzinga
Canaccord Genuity Group Trims Bioceres Crop Solutions (NASDAQ:BIOX) Target Price to $10.00 - MarketBeat
Bioceres Crop Solutions (NASDAQ:BIOX) PT Lowered to $10.00 at Canaccord Genuity Group - MarketBeat
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Update - MarketBeat
Bioceres Crop Solutions Corp (BIOX) Q4 2024 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance
(BIOX) Trading Report - Stock Traders Daily
Metric Analysis: Bioceres Crop Solutions Corp (BIOX)’s Key Ratios in the Limelight - The Dwinnex
BIOX stock touches 52-week low at $7.69 amid market challenges - Investing.com
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $13.63 Average PT from Brokerages - MarketBeat
Bioceres Announces 2024 Annual General Meeting - TipRanks
Enhancing The Tool Box For Crop Breeding Innovation - Forbes
Bioceres Crop Solutions reports consolidated financials - Investing.com India
Bioceres Reports Stable Financial Position - TipRanks
3 Bargain Stocks Under $20 With Major Growth Potential - MarketBeat
How to Take Advantage of moves in (BIOX) - Stock Traders Daily
Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper - Simply Wall St
Top 3 Materials Stocks You'll Regret Missing This QuarterH.B. Fuller (NYSE:FUL) - Benzinga
What is Berry Corp (BRY) Stock Return on Shareholders’ Capital? - SETE News
Epoch Investment Partners Inc. Takes Position in Berry Global Group, Inc. (NYSE:BERY) - Defense World
Finanzdaten der Bioceres Crop Solutions Corp-Aktie (BIOX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):